The EDF Guidelines gives the highest recommendation for fixed dose combinations of benzoyl peroxide (BPO) + clindamycin (Duac) or BPO + adaplene as first-line therapy in mild to moderate acne. 1Duac 5% helps patients to achieve treatment success faster than Zineryt. 2
The EDF Guidelines recommend against the use of topical antibiotic monotherapies to reduce the development of antibiotic resistance. Duac is 5% is more effective than monotherapies in reducing inflammatory lesions, with comparable tolerability. 1
Duac is a registered trademark of the GlaxoSmithKline group of companies.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
February 2020: PM-GB-CBP-WCNT-200004
Falsified Medicines Directive
Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.